Jayakumar S. Warrier

Person

Bannerghatta Road, IN

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted bicyclic compounds useful as T cell activators
- Patent number 11,964,973
- Issue date Apr 23, 2024
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 11,713,316
- Issue date Aug 1, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyridopyrimidinonyl compounds useful as T cell activators
- Patent number 11,584,747
- Issue date Feb 21, 2023
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TGF-beta inhibitors
- Patent number 11,352,360
- Issue date Jun 7, 2022
- Rigel Pharmaceuticals, hic.
- Todd Kinsella
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective NR2B antagonists
- Patent number 10,961,229
- Issue date Mar 30, 2021
- Bristol-Myers Squibb Company
- Imadul Islam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TGF beta receptor antagonists
- Patent number 10,961,239
- Issue date Mar 30, 2021
- Bristol-Myers Squibb Company
- Robert M. Borzilleri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 10,954,238
- Issue date Mar 23, 2021
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective NR2B antagonists
- Patent number 10,954,225
- Issue date Mar 23, 2021
- Bristol-Myers Squibb Company
- Imadul Islam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted naphthyridinone compounds useful as T cell activators
- Patent number 10,669,272
- Issue date Jun 2, 2020
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective NR2B antagonists
- Patent number 10,501,451
- Issue date Dec 10, 2019
- Bristol-Myers Squibb Company
- Imadul Islam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective NR2B antagonists
- Patent number 10,344,020
- Issue date Jul 9, 2019
- Bristol-Myers Squibb Company
- Imadul Islam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TGFβ receptor antagonist
- Patent number 10,336,761
- Issue date Jul 2, 2019
- Bristol-Myers Squibb Company
- Lalgudi S. Harikrishnan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TGF-β inhibitors
- Patent number 10,287,295
- Issue date May 14, 2019
- Rigel Pharmaceuticals, Inc.
- Todd Kinsella
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
GDF-8 inhibitors
- Patent number 9,981,944
- Issue date May 29, 2018
- Rigel Pharmaceuticals, Inc.
- Pingyu Ding
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TGF-beta inhibitors
- Patent number 9,884,868
- Issue date Feb 6, 2018
- Rigel Pharmaceuticals, Inc.
- Todd Kinsella
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phosphoramidic acid prodrugs of 5-[5-phenyl-4-(pyridin-2-ylmethylam...
- Patent number 9,238,666
- Issue date Jan 19, 2016
- Bristol-Myers Squibb Company
- Jayakumar S. Warrier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective NR2B antagonists
- Patent number 9,221,796
- Issue date Dec 29, 2015
- Bristol-Myers Squibb Company
- Dalton King
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazole prodrug LXR modulators
- Patent number 8,901,106
- Issue date Dec 2, 2014
- Bristol-Myers Squibb Company
- Ellen K. Kick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective NR2B antagonists
- Patent number 8,722,670
- Issue date May 13, 2014
- Bristol-Myers Squibb Company
- Dalton King
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prodrugs of a piperidinyl derivative as modulators of chemokine rec...
- Patent number 8,410,139
- Issue date Apr 2, 2013
- Bristol-Myers Squibb Company
- John Hynes
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMBINATION OF A T CELL THERAPY AND A DGK INHIBITOR
- Publication number 20240108654
- Publication date Apr 4, 2024
- Juno Therapeutics, Inc.
- David G. KUGLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20230151007
- Publication date May 18, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PIPERAZINE DERIVATIVES USEFUL AS T CELL ACTIVATORS
- Publication number 20230118629
- Publication date Apr 20, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED QUINAZOLINYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20230094758
- Publication date Mar 30, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATIONS OF DGK INHIBITORS AND CHECKPOINT ANTAGONISTS
- Publication number 20230089255
- Publication date Mar 23, 2023
- Bristol-Myers Squibb Company
- Susan WEE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED HETEROARYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20230086933
- Publication date Mar 23, 2023
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED QUINOLINONYL PIPERAZINE COMPOUNDS USEFUL AS T CELL ACTI...
- Publication number 20230061608
- Publication date Mar 2, 2023
- Bristol-Myers Squibb Company
- Louis S. Chupak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20220324859
- Publication date Oct 13, 2022
- Bristol-Myers Squibb Company
- Upender VELAPARTHI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20210188845
- Publication date Jun 24, 2021
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20210061802
- Publication date Mar 4, 2021
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE NR2B ANTAGONISTS
- Publication number 20200115370
- Publication date Apr 16, 2020
- Bristol-Myers Squibb Company
- Imadul Islam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20200109140
- Publication date Apr 9, 2020
- Bristol-Myers Squibb Company
- Upender VELAPARTHI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE NR2B ANTAGONISTS
- Publication number 20200071304
- Publication date Mar 5, 2020
- Bristol-Myers Squibb Company
- Imadul Islam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TGF-Beta Inhibitors
- Publication number 20200031832
- Publication date Jan 30, 2020
- Rigel Pharmaceuticals, Inc.
- Todd Kinsella
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TGF BETA RECEPTOR ANTAGONISTS
- Publication number 20190337942
- Publication date Nov 7, 2019
- Bristol-Myers Squibb Company
- Robert M. Borzilleri
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE NR2B ANTAGONISTS
- Publication number 20180312491
- Publication date Nov 1, 2018
- Bristol-Myers Squibb Company
- Imadul Islam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE NR2B ANTAGONISTS
- Publication number 20180312495
- Publication date Nov 1, 2018
- Bristol-Myers Squibb Company
- Imadul Islam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TGF BETA RECEPTOR ANTAGONISTS
- Publication number 20180250303
- Publication date Sep 6, 2018
- Bristol-Myers Squibb Company
- Robert M. Borzilleri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TGF-Beta Inhibitors
- Publication number 20180127426
- Publication date May 10, 2018
- Rigel Pharmaceuticals, Inc.
- Todd Kinsella
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GDF-8 Inhibitors
- Publication number 20160264553
- Publication date Sep 15, 2016
- Rigel Pharmaceuticals, Inc.
- Pingyu Ding
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TGF-Beta Inhibitors
- Publication number 20160257690
- Publication date Sep 8, 2016
- Rigel Pharmaceuticals, Inc.
- Todd Kinsella
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Selective NR2B Antagonists
- Publication number 20150191452
- Publication date Jul 9, 2015
- Bristol-Myers Squibb Company
- Dalton King
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHOSPHORAMIDIC ACID PRODRUGS OF 5-[5-PHENYL-4-(PYRIDIN-2-YLMETHYLAM...
- Publication number 20150175641
- Publication date Jun 25, 2015
- Bristol-Myers Squibb Company
- Jayakumar S. Warrier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZOLE PRODRUG LXR MODULATORS
- Publication number 20140018321
- Publication date Jan 16, 2014
- Ellen K. Kick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRODRUGS OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF CHEMOKINE REC...
- Publication number 20130178444
- Publication date Jul 11, 2013
- John Hynes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Selective NR2B Antagonists
- Publication number 20130085138
- Publication date Apr 4, 2013
- Bristol-Myers Squibb Company
- Dalton King
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PRODRUGS OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF CHEMOKINE REC...
- Publication number 20110082113
- Publication date Apr 7, 2011
- Bristol -Myers Squibb Company
- John Hynes
- C07 - ORGANIC CHEMISTRY

Jayakumar S. Warrier

Person

Patents Grantslast 30 patents

Substituted bicyclic compounds useful as T cell activators

Substituted naphthyridinone compounds useful as T cell activators

Substituted pyridopyrimidinonyl compounds useful as T cell activators

TGF-beta inhibitors

Selective NR2B antagonists

TGF beta receptor antagonists

Substituted naphthyridinone compounds useful as T cell activators

Selective NR2B antagonists

Substituted naphthyridinone compounds useful as T cell activators

Selective NR2B antagonists

Selective NR2B antagonists

TGFβ receptor antagonist

TGF-β inhibitors

GDF-8 inhibitors

TGF-beta inhibitors

Phosphoramidic acid prodrugs of 5-[5-phenyl-4-(pyridin-2-ylmethylam...

Selective NR2B antagonists

Imidazole prodrug LXR modulators

Selective NR2B antagonists

Prodrugs of a piperidinyl derivative as modulators of chemokine rec...

Patents Applicationslast 30 patents

COMBINATION OF A T CELL THERAPY AND A DGK INHIBITOR

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED PIPERAZINE DERIVATIVES USEFUL AS T CELL ACTIVATORS

SUBSTITUTED QUINAZOLINYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

COMBINATIONS OF DGK INHIBITORS AND CHECKPOINT ANTAGONISTS

SUBSTITUTED HETEROARYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED QUINOLINONYL PIPERAZINE COMPOUNDS USEFUL AS T CELL ACTI...

SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS T CELL ACTIVATORS

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

SELECTIVE NR2B ANTAGONISTS

SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

SELECTIVE NR2B ANTAGONISTS

TGF-Beta Inhibitors

TGF BETA RECEPTOR ANTAGONISTS

SELECTIVE NR2B ANTAGONISTS

SELECTIVE NR2B ANTAGONISTS

TGF BETA RECEPTOR ANTAGONISTS

TGF-Beta Inhibitors

GDF-8 Inhibitors

TGF-Beta Inhibitors

Selective NR2B Antagonists

PHOSPHORAMIDIC ACID PRODRUGS OF 5-[5-PHENYL-4-(PYRIDIN-2-YLMETHYLAM...

IMIDAZOLE PRODRUG LXR MODULATORS

PRODRUGS OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF CHEMOKINE REC...

Selective NR2B Antagonists

PRODRUGS OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF CHEMOKINE REC...